Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
International Journal of Cancer
|
April 10, 2026
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis
Núria Gendrau-Sanclemente, Agnès Figueras, Ferran Medina-Jover, et al.
Oncogene
|
March 16, 2019
PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma
Adrià Bernat-Peguera, Pilar Simón-Extremera, Victoria da Silva-Diz, et al.
Nature Communications
|
June 24, 2024
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, et al.
Cancer Research
|
January 1, 2016
Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression
Victoria da Silva-Diz, Pilar Simón-Extremera, Adrià Bernat-Peguera, et al.
Nature Communications
|
August 1, 2015
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Helena Serra, Iñigo Chivite, Ana Angulo-Urarte, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 19, 2019
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M
Marc Aragó, Juan Moreno-Felici, Sonia Abás, et al.
Nature Communications
|
November 18, 2018
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
Ana Angulo-Urarte, Pedro Casado, Sandra D Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Adrià Bernat-Peguera, Juan Navarro-Ventura, Laura Lorenzo-Sanz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 11, 2026
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors
Ferran Medina-Jover, Agnès Figueras, Núria Gendrau-Sanclemente, et al.
EMBO Molecular Medicine
|
May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
Álvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
International Journal of Cancer
|
April 10, 2026
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis
Núria Gendrau-Sanclemente, Agnès Figueras, Ferran Medina-Jover, et al.
Oncogene
|
March 16, 2019
PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma
Adrià Bernat-Peguera, Pilar Simón-Extremera, Victoria da Silva-Diz, et al.
Nature Communications
|
June 24, 2024
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, et al.
Cancer Research
|
January 1, 2016
Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression
Victoria da Silva-Diz, Pilar Simón-Extremera, Adrià Bernat-Peguera, et al.
Nature Communications
|
August 1, 2015
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Helena Serra, Iñigo Chivite, Ana Angulo-Urarte, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 19, 2019
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M
Marc Aragó, Juan Moreno-Felici, Sonia Abás, et al.
Nature Communications
|
November 18, 2018
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
Ana Angulo-Urarte, Pedro Casado, Sandra D Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Adrià Bernat-Peguera, Juan Navarro-Ventura, Laura Lorenzo-Sanz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 11, 2026
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors
Ferran Medina-Jover, Agnès Figueras, Núria Gendrau-Sanclemente, et al.
EMBO Molecular Medicine
|
May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
Álvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
Page
of 6